Status:
TERMINATED
Topical Hydromorphone for Wound Healing
Lead Sponsor:
Hordinsky, Maria K., MD
Conditions:
Wound Healing
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The hypothesis is that topical opioids will hasten wound healing in humans.
Detailed Description
This is based on our published data that morphine is a powerful stimulant of angiogenesis and our preclinical study of wounds in rats which demonstrate that topical opioids (morphine, hydromorphone an...
Eligibility Criteria
Inclusion
- Self-identified as normal, healthy volunteers age 18-65.
Exclusion
- Known bleeding disorder.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00177060
Start Date
October 1 2003
End Date
May 1 2007
Last Update
March 1 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455